(B)(4). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS THE DEVICE LOCATION IS UNKNOWN. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. CONCOMITANT MEDICAL PRODUCTS: 42532006702, TIBIA, LOT # 62331211; 42500606002, FEMUR, LOT # 62364751; 00111314001, BONE CEMENT, LOT # 76404338; 00111314001, BONE CEMENT, LOT # 76684363; 00111314001, BONE CEMENT, LOT # 77584367; 00111314001, BONE CEMENT, LOT # 76394338; 42540000032, POLY PATELLA, LOT # 62268836; 42522400512, BEARING, LOT # 62488904. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001822565-2018-02910, 3007963827-2018-00092, 0001822565-2018-02914, 0001822565-2018-02913, 0001822565-2018-02912, 0001822565-2019-04277.
D
Patient 1
IT WAS REPORTED THAT APPROXIMATELY 4 YEARS POST IMPLANTATION, THE PATIENT WAS REVISED OF THE RIGHT KNEE DUE TO ASEPTIC LOOSENING AND ARTHROFIBROSIS WITH LIMITED RANGE OF MOTION. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.